3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Pulmonary Embolism
1
Multiple Myeloma
1
Lymphoma
1
Leukemia
1
Hematologic Neoplasms
1
Interventions
fludarabine phosphate
9
Cyclophosphamide
8
Cyclosporine
7
Busulfan
6
Antilymphocyte Serum
6
fludarabine
5
Melphalan
5
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
Rivaroxaban
3
Radiotherapy
3
Methylprednisolone
3
Filgrastim
3
Cord Blood Stem Cell Transplantation
3
thymoglobulin
2
ferric carboxymaltose
2
apixaban
2
Whole-Body Irradiation
2
Therapeutics
2
Methotrexate
2
Heparin, Low-Molecular-Weight
2
Hematologic Tests
2
Genetic Counseling
2
Fondaparinux
2
Enoxaparin
2
Educational Status
2
Drug Therapy
2
Dalteparin
2
Cytarabine
2
sulforaphane
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
enoxaparin sodium
×
Classical hematology
×
Clear all
NCT07270263
2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA
Recruiting
100 enrolled